Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

3.87USD
17 Aug 2018
Change (% chg)

$0.02 (+0.52%)
Prev Close
$3.85
Open
$3.84
Day's High
$4.07
Day's Low
$3.83
Volume
58,378
Avg. Vol
149,636
52-wk High
$9.49
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.107
Mar '18 0.00 -0.122
FY 2017 Dec '17 0.00 -0.073
Sep '17 0.00 -0.133
Jun '17 0.00 -0.139
Mar '17 0.00 -0.154
FY 2016 Dec '16 0.00 -0.130
Sep '16 0.00 -0.159
Jun '16 0.00 -0.201
Mar '16 0.00 -0.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 2 -0.12 -0.11 -0.12 --
Quarter Ending Dec-18 2 -0.12 -0.11 -0.12 --
Year Ending Dec-18 2 -0.46 -0.45 -0.46 -0.79
Year Ending Dec-19 1 -1.06 -1.06 -1.06 -1.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 99.36 30.45
P/E High - Last 5 Yrs. -- 272.05 47.36
P/E Low - Last 5 Yrs. -- 95.21 24.74
Beta 2.59 0.78 0.84
Price to Sales (TTM) -- 126.22 5.98
Price to Book (MRQ) 191.05 13.00 3.69
Price to Tangible Book (MRQ) 14.94 22.28 5.63
Price to Cash Flow (TTM) -- 64.21 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.78
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.47 -5.93
Payout Ratio(TTM) -- 6.14 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 158.89 7.18
Sales (TTM) vs TTM 1 Yr. Ago -- 91.20 12.05
Sales - 5 Yr. Growth Rate -- 24.34 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 22.48 74.27 23.85
EPS (TTM) vs TTM 1 Yr. Ago 25.21 -- --
EPS - 5 Yr. Growth Rate -- 23.23 7.52
Capital Spending - 5 Yr. Growth Rate -- 36.95 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.50
Current Ratio (MRQ) 7.69 5.42 3.53
LT Debt to Equity (MRQ) 0.00 19.75 11.27
Total Debt to Equity (MRQ) 0.00 23.48 14.23
Interest Coverage (TTM) -- -186.89 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.13 55.23
Gross Margin - 5 Yr. Avg. -- 52.64 53.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -189.34 15.82
Operating Margin (TTM) -- -673.76 3.86
Operating Margin - 5 Yr. Avg. -- -202.74 10.95
Pre-Tax Margin (TTM) -- -665.74 4.16
Pre-Tax Margin - 5 Yr. Avg. -- -203.67 11.12
Net Profit Margin (TTM) -- -655.99 0.98
Net Profit Margin - 5 Yr. Avg. -- -201.27 7.47
Effective Tax Rate (TTM) -- 12.18 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,071,848 718,909,906
Net Income/Employee (TTM) -2,126,857 -6,208,777 83,624,743
Receivable Turnover (TTM) -- 6.39 5.38
Inventory Turnover (TTM) -- 2.25 3.51
Asset Turnover (TTM) 0.00 0.42 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -144.97 1.88 10.04
Return on Assets - 5 Yr. Avg. -95.66 2.31 10.94
Return on Investment (TTM) -190.97 2.89 12.63
Return on Investment - 5 Yr. Avg. -109.96 1.68 14.14
Return on Equity (TTM) -- 1.65 14.82
Return on Equity - 5 Yr. Avg. -259.75 -6.94 15.50
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.72 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galectin Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.67%
# of Holders: 76
Total Shares Held: 5,591,599
3 Mo. Net Change: 691,182
# New Positions: 21
# Closed Positions: 11
# Increased Positions: 43
# Reduced Positions: 26
# Net Buyers: 17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.